| pubmed-article:10613613 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10613613 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:10613613 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:10613613 | lifeskim:mentions | umls-concept:C0057223 | lld:lifeskim |
| pubmed-article:10613613 | lifeskim:mentions | umls-concept:C0008241 | lld:lifeskim |
| pubmed-article:10613613 | lifeskim:mentions | umls-concept:C0011816 | lld:lifeskim |
| pubmed-article:10613613 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:10613613 | lifeskim:mentions | umls-concept:C1332830 | lld:lifeskim |
| pubmed-article:10613613 | lifeskim:mentions | umls-concept:C1332828 | lld:lifeskim |
| pubmed-article:10613613 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:10613613 | lifeskim:mentions | umls-concept:C0678420 | lld:lifeskim |
| pubmed-article:10613613 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:10613613 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
| pubmed-article:10613613 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:10613613 | pubmed:dateCreated | 2000-1-4 | lld:pubmed |
| pubmed-article:10613613 | pubmed:abstractText | Dextromethorphan and chloroguanide (INN, proguanil) are used as prototypic phenotyping substrates of polymorphically expressed CYP2D6 and CYP2C19 in humans. We determined whether the dextromethorphan/dextrorphan and chloroguanide/cycloguanil metabolic ratios, obtained after administration of the parent drugs either alone or in combination, are equivalent. | lld:pubmed |
| pubmed-article:10613613 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10613613 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10613613 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10613613 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10613613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10613613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10613613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10613613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10613613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10613613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10613613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10613613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10613613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10613613 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10613613 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:10613613 | pubmed:issn | 0009-9236 | lld:pubmed |
| pubmed-article:10613613 | pubmed:author | pubmed-author:WilkinsonG... | lld:pubmed |
| pubmed-article:10613613 | pubmed:author | pubmed-author:Funck-Brentan... | lld:pubmed |
| pubmed-article:10613613 | pubmed:author | pubmed-author:BecquemontLL | lld:pubmed |
| pubmed-article:10613613 | pubmed:author | pubmed-author:PoirierJ MJM | lld:pubmed |
| pubmed-article:10613613 | pubmed:author | pubmed-author:TennezéLL | lld:pubmed |
| pubmed-article:10613613 | pubmed:author | pubmed-author:VerstuyftCC | lld:pubmed |
| pubmed-article:10613613 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10613613 | pubmed:volume | 66 | lld:pubmed |
| pubmed-article:10613613 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10613613 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10613613 | pubmed:pagination | 582-8 | lld:pubmed |
| pubmed-article:10613613 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:10613613 | pubmed:meshHeading | pubmed-meshheading:10613613... | lld:pubmed |
| pubmed-article:10613613 | pubmed:meshHeading | pubmed-meshheading:10613613... | lld:pubmed |
| pubmed-article:10613613 | pubmed:meshHeading | pubmed-meshheading:10613613... | lld:pubmed |
| pubmed-article:10613613 | pubmed:meshHeading | pubmed-meshheading:10613613... | lld:pubmed |
| pubmed-article:10613613 | pubmed:meshHeading | pubmed-meshheading:10613613... | lld:pubmed |
| pubmed-article:10613613 | pubmed:meshHeading | pubmed-meshheading:10613613... | lld:pubmed |
| pubmed-article:10613613 | pubmed:meshHeading | pubmed-meshheading:10613613... | lld:pubmed |
| pubmed-article:10613613 | pubmed:meshHeading | pubmed-meshheading:10613613... | lld:pubmed |
| pubmed-article:10613613 | pubmed:meshHeading | pubmed-meshheading:10613613... | lld:pubmed |
| pubmed-article:10613613 | pubmed:meshHeading | pubmed-meshheading:10613613... | lld:pubmed |
| pubmed-article:10613613 | pubmed:meshHeading | pubmed-meshheading:10613613... | lld:pubmed |
| pubmed-article:10613613 | pubmed:meshHeading | pubmed-meshheading:10613613... | lld:pubmed |
| pubmed-article:10613613 | pubmed:meshHeading | pubmed-meshheading:10613613... | lld:pubmed |
| pubmed-article:10613613 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10613613 | pubmed:articleTitle | Assessment of CYP2D6 and CYP2C19 activity in vivo in humans: a cocktail study with dextromethorphan and chloroguanide alone and in combination. | lld:pubmed |
| pubmed-article:10613613 | pubmed:affiliation | Clinical Investigation Center, St-Antoine University Hospital, and the Department of Pharmacology, Paris, France. | lld:pubmed |
| pubmed-article:10613613 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10613613 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10613613 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:10613613 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10613613 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
